Cogstate Ltd ( (AU:CGS) ) has issued an announcement.
Cogstate Ltd has announced a daily update on its ongoing on-market buy-back of ordinary fully paid securities. As of March 11, 2025, the company has bought back a total of 1,913,045 securities, with an additional 245,229 securities purchased on the previous day. This buy-back initiative is part of Cogstate’s strategy to manage its capital structure and potentially enhance shareholder value.
More about Cogstate Ltd
Cogstate Ltd operates in the healthcare industry, focusing on cognitive science and technology. The company provides cognitive assessment services and products, primarily targeting clinical trials and healthcare markets.
YTD Price Performance: 24.44%
Average Trading Volume: 10,950
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $149.1M
For a thorough assessment of CGS stock, go to TipRanks’ Stock Analysis page.